Over the last five decades, an empirical revolution in economics has undermined many of the assumptions of “neoliberalism,” the reigning approach to economic policy. Many of the guiding assumptions underlying neoliberal policymaking no longer speak to what is going on in the economy or our country more broadly. In “The Empirical Failures of Neoliberalism,” Roosevelt

The US economy has been structured by rules that either privilege or exploit people based on their race. Our nation’s legacy of implicit and explicit racial exclusions continue to have a deep impact on who is able to meaningfully participate and profit in the current American economy and who is left behind. The racialized policy

Today’s pharmaceutical industry is failing most Americans. Every day, a new story emerges about an outrageous price spike for a lifesaving drug, a fraud perpetrated on the American people in the name of profit, or the revolving door of administration officials entering an agency from a drug company or leaving to go to one—a practice

The rules of trade and of the global economy are failing too many. Due to false assumptions about the role of markets and the role of government in our economy, policymakers have narrowed their idea of international trade over the last 40 years, harming workers and hindering economic potential. By expanding our understanding of markets

On July 9 and 10, Federal Reserve Chair Jerome Powell testified before Congress regarding the Fed’s conduct of monetary policy. Both his prepared testimony and his responses to legislators’ pointed questioning marked a dramatic departure from the consensus that has long guided macroeconomic policy in the United States. When historians write the story of American

For too long, the building blocks of a good life, including solid benefits, strong wages, and safe working conditions, have been left to the whim of markets and employers rather than guaranteed for all. In today’s economy, curbing corporate and employer power and reclaiming public power are essential steps toward addressing the collective changes that

Structural problems in the health care and hospital industries are specifically hurting women in rural America, both as patients and as workers. In a new Roosevelt issue brief, Andrea Flynn, Rakeen Mabud, and Emma Chessen explore some of the industry-wide shifts that have occurred in rural areas over the last several decades. They then describe the

Despite Big Pharma’s claim that high-cost medicines are the price society must pay for innovation, recent research provides ample evidence that overpriced medicines are not necessary for the industry to find cures or revolutionize. Rather, high-cost and low-quality medicines are the price patients pay for an industry that prioritizes profit-seeking over public health. Like all

©Dano Wall

Without bold, visionary action to address race- and gender-based wealth inequities, the chasm between those who are economically secure and those who are not—mainly Black, brown, and Native American communities and women—will continue to grow. In the end, these issues threaten our nation’s ability to finally achieve our promise of freedom, dignity, and security for

In “The Cost of Capture: How the Pharmaceutical Industry Has Corrupted Policymakers and Harmed Patients,” Roosevelt Fellow Julie Margetta Morgan and Advocacy Associate Devin Duffy explore how drug companies influence policymakers and what this means for patients, the American health care system, and our economy. One of a series on Big Pharma, this issue brief